Reduction of pulmonary edema after SAH with a pulmonary artery catheter-guided hemodynamic management protocol

Neurocritical Care

Volumn 3, Issue 1, 2005, Pages 11-15

  Kim, Dong H ^a   Haney, Charles L ^a   Van Ginhoven, Grace ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Hypervolemia; Induced hypertension; Medical complications; Pulmonary edema; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ADULT; ARTERY CATHETER; ARTICLE; BLOOD VOLUME; CENTRAL VENOUS PRESSURE; COMORBIDITY; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HEART OUTPUT; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPERVOLEMIA; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; PRIORITY JOURNAL; PULMONARY ARTERY; SEPSIS; STATISTICAL SIGNIFICANCE; SUBARACHNOID HEMORRHAGE; TIME SERIES ANALYSIS; VASOSPASM;

CARDIAC OUTPUT; CATHETERIZATION; FEMALE; HEART DISEASES; HUMANS; HYPERTENSION; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; PULMONARY ARTERY; PULMONARY EDEMA; RETROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE;

EID: 24644434348     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/Neurocrit.Care2005;3:11-15     Document Type: Article

References (30)

1. Awad IA, Carte LP, Spetzler RF, Medina M, Williams FW Jr. Clinical vasospasm after subarachnoid hemorrhage-response to hypervolemic hemodilution and arterial hypertension. Stroke 1987;18:365-372.
2. Giannotta SL, McGillicuddy JE, Kindt GW. Diagnosis and treatment of postoperative cerebral vasospasm. Surg Neurol 1977;8:286-290.
3. Kassell NF, Peerless SJ, Cuward QJ. Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion. Neurosurgery 1978;3:364-368.
4. Kassell NF, Peerless SJ, Cuward QJ, Beck DW, Drake CG, Adams HP. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982;11:337-343.
5. Kassell NF, Sasaki T, Colohan ART. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985;16:562-572.
6. Kosnick EJ, Hunt WE. Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg 1976;45:148-154.
7. Lennihan L, Mayer SA, Fink ME, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 2000;31:383-391.
8. Levy ML, Giannotta SL. Cardiac performance indices during hypervolemic therapy for cerebral vasospasm. J Neurosurg 1991;75:27-31.
9. Mayberg MR. Cerebral vasospasm. Neurosurgery Clinics of North America 1998;9:615-627.
10. Miller JA, Dacey RG, Diringer MN. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke 1995;26:2260-2266.
11. Origitano TC, Wascher TM, Reichman OH, Anderson DE. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("Triple-H" therapy) after subarachnoid hemorrhage. Neurosurgery 1990;27:729-740.
12. Otsubo H, Takemae T, Inoue T, Kobayashi SH, Sugita K. Normovolemic induced hypertension therapy for cerebral vasospasm after subarachnoid hemorrhage. Acta Neurochir (Wien) 1990;103:18-26.
13. Rosenwasser RH, Delgado TE, Buchheit WA. Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage; a preliminary report. Neurosurgery 1983;12:658-661.
14. Solomon RA, Fink ME, Lennihan L. Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage. Neurosurgery 1988;23:699-704.
15. Vander Ark GD, Pomerants M. Reversal of ischemic neurological signs by increasing cardiac output. Surg neurol 1973; 1:257,258.
16. Treggiari MM, Walder B, Suter PM, Romand JA. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 2003;98:978-984.
17. Egge A, Waterloo K, Sjoholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurismal subarachnoid hemorrhage; a clinical prospective, randomized, controlled study. Neurosurgery 2001;49(3):593-606.
18. Oropello JM, Weiner L, Benjamin E. Hypertensive, hypervolemic, hemodilutional therapy for aneurysmal subarachnoid hemorrhage-is it efficacious? No. Critical Care Clinics 1996;12(3):710-731.
19. Findlay JM, Deagle GM. Causes of morbidity and mortality following intracranial aneurysm rupture. Can J Neurol Sci 1998;25:209-215.
20. Friedman JA, Pichelmann MA, Pipgras DG, et al. Pulmonary Complications of aneurysmal subarachnoid hemorrhage. Neurosurgery 2003;52:1025-1032.
21. Gruber A, Reinprecht A, Illievich UM, et al. Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Crit Care Med 1999;27(3):505-514.
22. Haley EC Jr, Kassell NF, Torner JC. The international cooperative study on the timing of aneurysm surgery; the North American experience. Stroke 1992;23(2):205-214.
23. Vermeij FJ, Hasan D, Bijvoet HWC, Avezaat CJJ. Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage. Stroke 1998;29:924-930.
24. Weir B, Grace M, Hansen J, Rothberg C. Time course of vasospasm in man. J Neurosurg 1978;48:173-178.
25. Medlock MD, Dulebohn SC, Elwood PW. Prophylactic hypervolemia without calcium channel blockers in early aneurysm surgery. Neurosurgery 1992;30:12-16.
26. Solenski NJ, Haley EC, Jr, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Crit Care Med 1995;23(6):1007-1012.
27. Kim DH, Joseph M, Ziadi S, et al. Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: s study using xenon-CT measurements of cerebral blood flow. Neurosurgery 2003;53:1-9.
28. Pittman JA, Ping JS, Mark JB. Arterial and central venous pressure monitoring. Int Anesthisiol Clin 2004;42:13-30.
29. Tkachenko RL, Evlakhov VI, Poyasov IZ. Independence of changes in right atrial pressure and central venous pressure. Bull Exp Biol Med 2002;134:318-320.
30. Levy ML, Rabb CH, Zelman V, Giannotta SL. Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm. J Neurosurg 1993;79:494-499.